Skip to main content
See every side of every news story
Published loading...Updated

Sandip Prasad, MD, on key data from pivotal ENVISION trial of mitomycin intravesical solution

Summary by urologytimes.com
Sandip M. Prasad, MD, MPhil, details key findings from the phase 3 ENVISION trial, which supported the approval of mitomycin intravesical solution in LG-IR-NMIBC.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

urologytimes.com broke the news in on Friday, August 15, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal